MarginsXMarginsX
Home › Markets › Health Care › CDT

CDT Equity Inc. (CDT)

CDT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3770
-5.84% on the day
Market cap
$384K
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCDT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2022
SEC CIK0001896212
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
0.8 months
$747K cash at June 30, 2026
Share count, 1 year
+51282.3%
2025-08-14 to 2026-08-12 · +3241058.7% over 3 years
Going-concern doubt
Yes
10-Q filed August 12, 2026
Insider net buying, 12 months
-$2.9M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern for at least the next 12 months from the financial statement filing date."
10-Q 2026-08-12
Cash and burn$747K cash; operating cash flow -$2.9M a quarter.Report 2026-06-30
Shares outstanding1,573,340 (2026-08-12); 3,062,025,000 a year earlier; 72,813,776,000 three years earlier. 1y figure adjusted for splits (1-for-2000 overall); 3y figure adjusted for splits (1-for-3000000 overall).Cover page 2026-08-12
Reverse splits, 3 years7; latest 1-for-20 on 2026-11-06Source 2026-11-06
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedownsLatest 2026-04-02
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-05-28
AuditorCBIZ CPAs P.C., New York, New York, United States; changed auditors 2 times in 24 months8-K 4.01 2026-06-29
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-15
Insider trades, 12 monthsBought $0, sold $2.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 1,017,862 shares at the 2026-11-13 price; the latest SEC cover count is 1,573,340 as of 2026-08-12, 1,573,340 after the 1-for-25 and 1-for-20 splits since. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$4.6M-$544K$747KNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$4.1M-$1.9M$97KNo debt tagsNeeds four quarters10-Q 2026-07-15
Q4 2025
2025-12-31
Not filed-$21.3M-$4.6M$1.5MNo debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$7.1M-$4.4M$3.8MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$6.0M-$2.6M$3.3MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$4.8M-$3.9M$2.1MNo debt tagsNeeds four quarters10-Q 2026-07-15
Q4 2024
2024-12-31
Not filed-$2.4M-$3.8M$554K$1.8MNeeds four quarters10-K 2026-04-15
Q3 2024
2024-09-30
Not filed-$6.5M-$2.0M$71K$2.5MNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-16
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-10-27

Source: SEC EDGAR submissions feed, 374 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-69.5%
1 month-95.6%
3 months-100.0%
Year to date-100.0%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
CDTTWCDT Equity Inc. Warrant$0.0070

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
LABTLakewood-Amedex Biotherapeutics Inc.$0.2194-22.31%$520K
SPRCSciSparc Ltd.$0.3307-10.62%$815K
OGENOragenics Inc.$0.1980-1.49%$893K
MTNBMatinas Biopharma Holdings Inc.$0.9270+3.00%$908K
GOVXGeoVax Labs Inc.$2.02+18.48%$1.1M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$2.24-6.28%$1.2M
ELABPMGC Holdings Inc.$1.66+5.06%$1.3M
KAPAKairos Pharma Ltd.$0.4069-10.30%$1.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier